The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 9, 1997, Pages 381-384

  Puljevic, D ^a,c   Smalcelj, A ^a   Durakovic, Z ^b   Goldner, V ^a  

^a Clinic for Cardiovascular Diseases   (Croatia)

^b UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Atenolol; Propafenone; QT dispersion

Indexed keywords

ATENOLOL; PROPAFENONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPAFENONE;

EID: 0030776304     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ahnve S, Erhardt L, Lundman T, Rehnqist N, Sjogren A 1980 Effects of metoprolol on QTc intervals after acute myocardial infarction. Acta Med Scand 208: 223-228
2. Barr CS, Nass A, Freeman M, Langtry CC, Struthers AD 1994 QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343: 327-329
3. Bryson MM, Palmer KJ, Langtry HD, Fitton A 1993 Propefenone. A reappraisal of its pharmacology, pharmacokinetics, and therapeutic use in cardiac arrhythmias. Drugs 45: 85-130
4. Buja C, Miorelli M, Turrini P, Melacini P, Nava A 1993 Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 72: 973-976
5. Buss I, Neuss H, Bilgin Y, Schlepper M 1985 Malignant ventricular tachyarrhythmias in association with propafenone treatment. Eur Heart J 65: 424-428
6. Day CP, McComb JM, Campbell RWF 1990 QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63: 342-344
7. Day CP, McComb JM, Mathews J, Campbell RWF 1991 Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 12: 423-427
8. Dritsas A, Gilligan D, Niboyannopoulos P, Oakley CM 1992 Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy. Int J Cardiol 36: 345-349
9. Hernandez M, Reder RF, Morinchak RA, Rials SJ, Kowey PR 1991 Propafenone for malignant ventricular arrhythmia: an analysis of the literature. Am Heart J 121 : 1178-1184
10. Higham PD, Campbell RWF 1994 QT dispersion. Br Heart J 71: 508-510
11. Hii JTY, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB 1992 Precordial QT interval dispersion as a marker of torsade de pointes. Circulation 68: 1376-1382
12. Hohnloser SH, van de Loo A, Arendts W, Zabel M, Just H 1993 QT dispersion im Oberflächen-EKG als Parameter einer gesteigerten elektrischen Vulnerabilität bei akuter Myokardoschämie. Z Kardiol 82: 678-682
13. Huikuri HV, Cox M, Interian A, Kessier KM, Glicksman F, Castellanos A, Myerburg RJ 1989 Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease. Am J Cardiol 64: 1305-1309
14. Kuck KM 1992 Medical versus ICD treatment in survivors of sudden cardiac death. 10th International Congress "New Frontiers of Arrhythmias". Marillera, Italy, pp 89-92
15. McLaughln NB, Campbell RWF, Murray A 1995 Comparison of automatic QT measurement techniques in the normal 12-lead electrocardiogram. Br Heart J 74: 84-89
16. Perkiomaki JS, Koistinen MJ, Yli-Mayry S, Huikuri HV 1995 Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 26: 174-179
17. Priori SG. Napolitano C, Diehl L, Schwarz PJ 1994 Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 39: 1681-1689
18. Rogers WJ, CAST investigators 1989 The Cardiac Arrhythmia Supression Trial (CAST). N Engl J Med 321: 406-412
19. Sweeney MO, Moss AJ, Eberly S 1992 Instantaneous cardiac death in the posthospital period after acute myocardial infarction. Am J Cardiol 70: 1375-1379
20. Vincent GM, Timothy K, Zong Cui C, Wen Ding H, Zhang L 1992 In LQTS, beta-blockers reduce QT, QTc and T morphology abnormalities during exercise: this may be the mechanism of therapeutic benefit. Circulation 86 (Suppl I): 1-393
21. Wit AL, Coromilas J 1993 Role of alterations in refractoriness and conduction in the genesis of reentrant arrhythmias. Am J Cardiol 72: 3F-12F
22. Zabel M, Portnoy S, Franz MR 1995 Electrocardiographs indexes of dispersion of ventricular repolarisation: an isolated heart validation study. J Am Coll Cardiol 25: 746-752
23. Zipes DP 1992 Management of cardiac arrhythmias: Pharmacological, electrical and surgical techniques. In: Braunwald E (ed) Heart Disease (4th ed). Saunders, Philadelphia, pp 644